X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.290
+0.150 (3.62%)
Apr 17, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Discovery, Development and Commercialization of Novel Therapeutics | 35.11M | 2.56M | - | - | | 3.00M | | | | |
Discovery, Development and Commercialization of Novel Therapeutics Growth | 1273.21% | - | - | - | | - | | | | |
| 35.11M | 2.56M | - | - | | 3.00M | | | | |
| 1273.21% | - | - | - | | - | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 6.50M | 2.60M | - | - | | 3.00M | | | | |
| 150.00% | - | - | - | | - | | | | |
| 28.60M | - | - | - | | - | | | | |
| 35.10M | 2.60M | - | - | | 3.00M | | | | |
| 1250.00% | - | - | - | | - | | | | |
Source: S&P Global Market Intelligence.
